Chronic renal disease initiation and progression remain incompletely understood. Genomewide expression monitoring should clarify the mechanisms which cause progressive renal disease by determining how clusters of genes coordinately change their activity. Serial analysis of gene expression (SAGE) is a technique of expression profiling which permits simultaneous and quantitative analysis of 9- to 13-bp sequence tags that correspond to unique mRNAs. Key principles of the technique are use of PCR in a manner to minimize distortion and serial concatenation of tags which facilitates sequencing and permits identification of many expressed genes in a single cDNA molecule. Tags are extracted from many concatenated sequences, counted using software, and identified by comparison with existing gene databases. In aggregate, gene expression profiles generated from a tag library comprise a transcriptome which represents a comprehensive and quantitative profile of genes expressed at the time of analysis. These global snapshots of gene expression patterns can better define basic cell biology and provide insights into disease pathogenesis by simultaneously determining the net consequences of gene-gene and gene-environment interactions on expression of thousands of genes. Rather than applying a priori assumptions (i.e., hypothesis testing), transcriptome analysis is hypothesis generating and requires no prior knowledge of gene expression. SAGE kidney transcriptomes, from normal animals and animals with progressive kidney disease, are being produced and can be analyzed for novel pathogenetic mechanisms. The use of SAGE and other genomic and proteomic tools should result in a better understanding of kidney disease pathogenesis and in identification of new therapeutic targets.

Keywords:
SAGE, Kidney transcriptomes, Genomic/proteomic tools
1.
Border WA, Noble NA: TGF-β in kidney fibrosis: A target for gene therapy. Kidney Int 1997;51:1388–1396.
2.
Brenner BM, Lawler EV, Mackenzie HS: The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int 1996;49:1774–1777.
3.
Schelling JR, Zarif L, Sehgal AR, Iyengar S, Sedor JR: Genetic susceptibility to end-stage renal disease. Curr Opin Nephrol Hypertens 1999;8:465–472.
4.
Amson RB, Nemani M, Roperch JP, et al: Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: Activation of the vertebrate homologue of the drosophila seven in absentia gene. Proc Natl Acad Sci USA 1996;93:3953–3957.
5.
Babity JM, Armstrong JN, Plumier JC, Currie RW, Robertson HA: A novel seizure-induced synaptotagmin gene identified by differential display. Proc Natl Acad Sci USA 1997;94:2638–2641.
6.
Stevens CJM, Te Kronnie G, Samallo J, Schipper H, Stroband HWJ: Isolation of carp cDNA clones, representing developmentally-regulated genes, using a subtractive-hybridization strategy. Roux Arch Dev Biol 1996;205:460–467.
7.
Kohda Y, Murakami H, Moe OW, Star RA: Analysis of segmental renal gene expression by laser capture microdissection. Kidney Int 2000;57:321–331.
8.
Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science 1995;270:484–487.
9.
Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467–470.
10.
Yamamoto M, Wakatsuki T, Hada A, Ryo A: Use of serial analysis of gene expression (SAGE) technology. J Immunol Methods 2001;250:45–66.
11.
Green CD, Simons JF, Taillon BE, Lewin DA: Open systems: Panoramic views of gene expression. J Immunol Methods 2001;250:67–79.
12.
Lash AE, Tolstoshev CM, Wagner L, Schuler GD, Strausberg RL, Riggins GJ, Altschul SF: SAGEmap: A public gene expression resource. Genome Res 2000;10:1051–1060.
13.
El-Meanawy MA, Schelling JR, Pozuelo F, Churpek MM, Ficker EK, Iyengar S, Sedor JR: Use of serial analysis of gene expression to generate kidney expression libraries. Am J Physiol 2000;279:F383–F392.
14.
Emmert-Buck MR, Strausberg RL, Krizman DB, Bonaldo MF, Bonner RF, Bostwick DG, Brown MR, Buetow KH, Chuaqui RF, Cole KA, Duray PH, Englert CR, Gillespie JW, Greenhut S, Grouse L, Hillier LW, Katz KS, Klausner RD, Kuznetzov V, Lash AE, Lennon G, Linehan WM, Liotta LA, Marra MA, Munson PJ, Ornstein DK, Prabhu VV, Prange C, Schuler GD, Soares MB, Tolstoshev CM, Vocke CD, Waterston RH: Molecular profiling of clinical tissue specimens: Feasibility and applications. Am J Pathol 2000;156:1109–1115.
15.
Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, Xiao H, Rogers KE, Wan JS, Jackson MR, Erlander MG: Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med 1999;5:117–122.
16.
Datson NA, Van der Perk-de Jong J, Van den Berg MP, de Kloet ER, Vreugdenhil E: MicroSAGE: A modified procedure for serial analysis of gene expression in limited amounts of tissue. Nucleic Acids Res 1999;27:1300–1307.
17.
Virlon B, Cheval L, Buhler JM, Billon E, Doucet A, Elalouf JM: Serial microanalysis of renal transcriptomes. Proc Natl Acad Sci USA 1999;96:15286–15291.
18.
Ye SQ, Zhang LQ, Zheng F, Virgil D, Kwiterovich PO: MiniSAGE: Gene expression profiling using serial analysis of gene expression from 1 μg total RNA. Anal Biochem 2000;287:144–152.
19.
Powell J: Enhanced concatemer cloning – a modification to the SAGE (Serial Analysis of Gene Expression) technique. Nucleic Acids Res 1998;26:3445–3446.
20.
Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science 1997;276:1268–1272.
21.
Pauws E, Van Kampen AHC, Van de Graaf SAR, De Vijlder JJM, Ris-Stalpers C: Heterogeneity in polyadenylation cleavage sites in mammalian mRNA sequences: Implications for SAGE analysis. Nucleic Acids Res 2001;29:1690–1694.
22.
Stollberg J, Urschitz J, Urban Z, Boyd CD: A quantitative evaluation of SAGE. Genome Res 2000;10:1241–1248.
23.
Velculescu VE, Madden SL, Zhang L, et al: Analysis of human transcriptomes. Nat Genet 1999;23:387–388.
24.
Gygi SP, Rochon Y, Franza BR, Aebersold R: Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19:1720–1730.
25.
Ryo A, Kondoh N, Wakatsuki T, Hada A, Yamamoto N, Yamamoto M: A modified serial analysis of gene expression that generates longer sequence tags by nonpalindromic cohesive linker ligation. Anal Biochem 2000;277:160–162.
26.
Velculescu VE, Zhang L, Zhou W, Vogelstein J, Basrai MA, Bassett DE Jr, Hieter P, Vogelstein B, Kinzler KW: Characterization of the yeast transcriptome. Cell 1997;88:243–251.
27.
Madden SL, Galella EA, Zhu JS, Bertelsen AH, Beaudry GA: SAGE transcript profiles for p53-dependent growth regulation. Oncogene 1997;15:1079–1085.
28.
Audic S, Claverie JM: The significance of digital gene expression profiles. Genome Res 1997;7:986–995.
29.
Man MZ, Wang XN, Wang YX: Power SAGE: Comparing statistical tests for SAGE experiments. Bioinformatics 2000;16:953–959.
30.
Stoeckert C, Pizarro A, Manduchi E, Gibson M, Brunk B, Crabtree J, Schug J, Shen-Orr S, Overton GC: A relational schema for both array-based and SAGE gene expression experiments. Bioinformatics 2001;17:300–308.
31.
Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B: A model for p53-induced apoptosis. Nature 1997;389:300–305.
32.
Hibi K, Liu Q, Beaudry GA, Madden SL, Westra WH, Wehage SL, Yang SC, Heitmiller RF, Bertelsen AH, Sidransky D, Jen J: Serial analysis of gene expression in non-small cell lung cancer. Cancer Res 1998;58:5690–5694.
33.
Nacht M, Ferguson AT, Zhang W, Petroziello JM, Cook BP, Gao YH, Maguire S, Riley D, Coppola G, Landes GM, Madden SL, Sukumar S: Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res 1999;59:5464–5470.
34.
Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B: Identification and classification of p53-regulated genes. Proc Natl Acad Sci USA 1999;96:14517–14522.
35.
Welle S, Bhatt K, Thornton CA: Inventory of high-abundance mRNAs in skeletal muscle of normal men. Genome Res 1999;9:506–513.
36.
Pauws E, Moreno JC, Tijssen M, Baas F, De Vijlder JJM, Ris-Stalpers C: Serial analysis of gene expression as a tool to assess the human thyroid expression profile and to identify novel thyroidal genes. J Clin Endocrinol Metab 2000;85:1923–1927.
37.
Yamashita T, Kaneko S, Hashimato S, Sato T, Nagai S, Toyoda N, Suzuki T, Kobayashi K, Matsushima K: Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma. Biochem Biophys Res Commun 2001;282:647–654.
38.
Takenaka M, Imai E, Kaneko T, Ito T, Moriyama T, Yamauchi A, Hori M, Kawamoto S, Okubo K: Isolation of genes identified in mouse renal proximal tubule by comparing different gene expression profiles. Kidney Int 1998;53:562–572.
39.
Magnuson T, Epstein CJ: Oligosyndactyly: A lethal mutation in the mouse that results in mitotic arrest very early in development. Cell 1984;38:823–833.
40.
Zalups RK: The Os/+ mouse: A genetic animal model of reduced renal mass. Am J Physiol 1993;264:F53–F60.
41.
He CJ, Esposito C, Phillips C, Zalups RK, Henderson DA, Striker GE, Striker LJ: Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest 1996;97:1242–1249.
42.
Jenssen TK, Laegreid A, Komorowski J, Hovig E: A literature network of human genes for high-throughput analysis of gene expression. Nat Genet 2001;28:21–28.
43.
Barathan S, Konieczkowski M, El-Meanawy MA, Khan S, Wang B, Dodig T, Iyengar SK, Schelling JR, Sedor JR: Expression analysis demonstrates the cell guidance signal neuropilin 2b is reduced in sclerosis-prone ROP-Os/+ but not sclerosis-resistant C57BL/6-Os/+ mouse kidneys (abstract). J Am Soc Nephrol 2001;12:809.
44.
Ishii M, Hashimoto S, Tsutsumi S, Wada Y, Matsushima K, Kodama T, Aburatani H: Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis. Genomics 2000;68:136–143.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.